Tenoxicam
Composition
The formulation contains Tenoxicam 20 mg/ml with mannitol, tromethamine, and water for injection as the active ingredient.
Indications
Indicated for the relief of pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis, and postoperative pain.
Side effects
Common side effects include gastrointestinal issues such as nausea, vomiting, abdominal pain, and dyspepsia; other side effects can include dizziness, headache, and skin reactions.
Precautions
To be used with caution in patients with a history of gastrointestinal bleeding or renal impairment.
Contraindications
Contraindicated in patients with a history of hypersensitivity to Tenoxicam or other NSAIDs.
Dosage and administration
The recommended dosage is usually 20 mg once daily, administered intramuscularly or intravenously.
Countries
Available globally.
Available Forms
Injection
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai